These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

444 related items for PubMed ID: 11757799

  • 1. Immunization against tumor cell surface complement-regulatory proteins.
    Durrant LG, Spendlove I.
    Curr Opin Investig Drugs; 2001 Jul; 2(7):959-66. PubMed ID: 11757799
    [Abstract] [Full Text] [Related]

  • 2. Expression of CD46, CD55, and CD59 on renal tumor cell lines and their role in preventing complement-mediated tumor cell lysis.
    Gorter A, Blok VT, Haasnoot WH, Ensink NG, Daha MR, Fleuren GJ.
    Lab Invest; 1996 Jun; 74(6):1039-49. PubMed ID: 8667608
    [Abstract] [Full Text] [Related]

  • 3. Complement regulatory proteins in normal human esophagus and esophageal squamous cell carcinoma.
    Shimo K, Mizuno M, Nasu J, Hiraoka S, Makidono C, Okazaki H, Yamamoto K, Okada H, Fujita T, Shiratori Y.
    J Gastroenterol Hepatol; 2004 Jun; 19(6):643-7. PubMed ID: 15151618
    [Abstract] [Full Text] [Related]

  • 4. Human carcinomas variably express the complement inhibitory proteins CD46 (membrane cofactor protein), CD55 (decay-accelerating factor), and CD59 (protectin).
    Niehans GA, Cherwitz DL, Staley NA, Knapp DJ, Dalmasso AP.
    Am J Pathol; 1996 Jul; 149(1):129-42. PubMed ID: 8686736
    [Abstract] [Full Text] [Related]

  • 5. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC, Cornell RJ, Zhou JY, Zhou JT, Hirsch VM, Johnson PR.
    Virology; 1994 Nov 15; 205(1):82-92. PubMed ID: 7526538
    [Abstract] [Full Text] [Related]

  • 6. Levels of cell membrane CD59 regulate the extent of complement-mediated lysis of human melanoma cells.
    Brasoveanu LI, Altomonte M, Fonsatti E, Colizzi F, Coral S, Nicotra MR, Cattarossi I, Cattelan A, Natali PG, Maio M.
    Lab Invest; 1996 Jan 15; 74(1):33-42. PubMed ID: 8569195
    [Abstract] [Full Text] [Related]

  • 7. Complement regulatory proteins are expressed at low levels in embryonic human, wild type and transgenic porcine neural tissue.
    Harrower TP, Richards A, Cruz G, Copeman L, Dunnett SB, Barker RA.
    Xenotransplantation; 2004 Jan 15; 11(1):60-71. PubMed ID: 14962294
    [Abstract] [Full Text] [Related]

  • 8. Controlling complement resistance in cancer by using human monoclonal antibodies that neutralize complement-regulatory proteins CD55 and CD59.
    Ziller F, Macor P, Bulla R, Sblattero D, Marzari R, Tedesco F.
    Eur J Immunol; 2005 Jul 15; 35(7):2175-83. PubMed ID: 15971270
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Membrane-bound regulators of complement activation in uveal melanomas. CD46, CD55, and CD59 in uveal melanomas.
    Goslings WR, Blom DJ, de Waard-Siebinga I, van Beelen E, Claas FH, Jager MJ, Gorter A.
    Invest Ophthalmol Vis Sci; 1996 Aug 15; 37(9):1884-91. PubMed ID: 8759358
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Expression of complement membrane regulators membrane cofactor protein (CD46), decay accelerating factor (CD55), and protectin (CD59) in human malignant gliomas.
    Mäenpää A, Junnikkala S, Hakulinen J, Timonen T, Meri S.
    Am J Pathol; 1996 Apr 15; 148(4):1139-52. PubMed ID: 8644856
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Expression of the complement regulatory proteins decay accelerating factor (DAF, CD55), membrane cofactor protein (MCP, CD46) and CD59 in the normal human uterine cervix and in premalignant and malignant cervical disease.
    Simpson KL, Jones A, Norman S, Holmes CH.
    Am J Pathol; 1997 Nov 15; 151(5):1455-67. PubMed ID: 9358772
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.